Mucormycosis and COVID 19: From the desk of a periodontist
Oral mucormycosis is not a new disease and is known to occur in patients with low immunity such as in uncontrolled diabetes, posttransplant, and some cancer treatments. A sudden surge has been reported in mucormycosis in cases with COVID-19. Although rare, serious complication of COVID-19. The aim o...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-01-01
|
| Series: | Apollo Medicine |
| Subjects: | |
| Online Access: | http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2021;volume=18;issue=3;spage=184;epage=186;aulast=Singh |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Oral mucormycosis is not a new disease and is known to occur in patients with low immunity such as in uncontrolled diabetes, posttransplant, and some cancer treatments. A sudden surge has been reported in mucormycosis in cases with COVID-19. Although rare, serious complication of COVID-19. The aim of this article is to discuss the periodontal presentation of oral mucormycosis in patients who currently have or have recovered from COVID-19 infection. Although fatal sometime, its successful treatment lies in the early diagnosis and for periodontists are the first doctors to identify the same, they should remain vigilant in its diagnosis so that the same can be treated by a multidisciplinary medical approach and fatalities can be avoided. |
|---|---|
| ISSN: | 0976-0016 2213-3682 |